UBS Group
SKIN icon

UBS Group’s SkinHealth Systems SKIN Stock Holding History

UBS Group’s Portfolio SKIN Stock Details SKIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$582K Buy
839,383
+599,031
+249% +$458K ﹤0.01% 6138
2026
Q1 		$214K Sell
240,352
-97,473
-29% -$120K ﹤0.01% 6600
2025
Q4 		$470K Buy
337,825
+88,271
+35% +$128K ﹤0.01% 6123
2025
Q3 		$497K Sell
249,554
-55,072
-18% -$112K ﹤0.01% 6102
2025
Q2 		$582K Sell
304,626
-480,136
-61% -$676K ﹤0.01% 5880
2025
Q1 		$1.05M Sell
784,762
-267,972
-25% -$409K ﹤0.01% 5253
2024
Q4 		$1.67M Buy
1,052,734
+992,704
+1,654% +$1.56M ﹤0.01% 4902
2024
Q3 		$86.4K Sell
60,030
-39,614
-40% -$64.9K ﹤0.01% 6458
2024
Q2 		$191K Sell
99,644
-309,751
-76% -$872K ﹤0.01% 5683
2024
Q1 		$1.82M Buy
409,395
+402,643
+5,963% +$1.31M ﹤0.01% 4043
2023
Q4 		$21K Buy
6,752
+5,152
+322% +$19.3K ﹤0.01% 7077
2023
Q3 		$9.63K Sell
1,600
-61,947
-97% -$435K ﹤0.01% 7129
2023
Q2 		$532K Buy
63,547
+16,277
+34% +$169K ﹤0.01% 4770
2023
Q1 		$597K Buy
47,270
+26,857
+132% +$311K ﹤0.01% 4554
2022
Q4 		$186K Buy
20,413
+14,938
+273% +$161K ﹤0.01% 5518
2022
Q3 		$64K Buy
5,475
+26
+0.5% +$329 ﹤0.01% 6107
2022
Q2 		$70K Sell
5,449
-2,848
-34% -$38.2K ﹤0.01% 5680
2022
Q1 		$140K Sell
8,297
-35,205
-81% -$581K ﹤0.01% 5648
2021
Q4 		$1.05M Buy
43,502
+2,476
+6% +$63.8K ﹤0.01% 4347
2021
Q3 		$1.07M Sell
41,026
-28,037
-41% -$617K ﹤0.01% 4152
2021
Q2 		$1.16M Buy
69,063
+68,102
+7,087% +$931K ﹤0.01% 4053
2021
Q1 		$10K Buy
+961
New +$10.6K ﹤0.01% 7941

Other funds holding SKIN

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

UBS Group's SKIN Position: Q2 2026 in Review

UBS Group increased its SkinHealth Systems (SKIN) stake by 249% in Q2 2026, buying an estimated $458K and bringing the position to 839,383 shares worth $582K. The position accounts for ﹤0.01% of the portfolio, ranked #6138.

UBS Group first reported a position in SKIN in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.82M in Q1 2024. 96 funds tracked by Wall St. Rank hold SKIN as of Q2 2026.

  • UBS Group held 839,383 shares of SkinHealth Systems worth $582K as of Q2 2026.
  • UBS Group bought 599,031 SkinHealth Systems shares in Q2 2026, an estimated $458K.
  • SkinHealth Systems made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6138 holding.
  • UBS Group first reported a position in SkinHealth Systems in Q1 2021 and has held it in 22 quarters since.
  • UBS Group's SkinHealth Systems position peaked at $1.82M in Q1 2024.
  • 96 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.